Divis Laboratories Intrinsic Value
Divis Laboratories (DIVISLAB) median intrinsic value is ₹4507.17 from 10 valuation models (range ₹2192–₹8219), vs current price ₹7305.00 — -38.3% downside (Trading Above Calculated Value), margin of safety -62.1%. For current market price and key ratios, visit DIVISLAB share price screener.
DIVISLAB Valuation Methods Summary — DCF, Graham Number & P/E
Divis Laboratories intrinsic value across 10 models vs current price ₹7305.00 — upside/downside and value range per method. Analyse DIVISLAB FII DII holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2491.28 | ₹1993.02 - ₹2989.54 | -65.9% | EPS: ₹113.24, Sector P/E: 22x |
| Book Value Method | asset | ₹6324.91 | ₹5692.42 - ₹6957.40 | -13.4% | Book Value/Share: ₹3162.45, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹4507.17 | ₹4056.45 - ₹4957.89 | -38.3% | Revenue/Share: ₹2253.58, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹8218.87 | ₹7396.98 - ₹9040.76 | +12.5% | EBITDA: ₹4356.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹5682.31 | ₹4545.85 - ₹6818.77 | -22.2% | CF Growth: 9.4%, Discount: 15% |
| PEG Ratio Method | growth | ₹2191.50 | ₹1972.35 - ₹2410.65 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2191.50 | ₹1972.35 - ₹2410.65 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹7935.09 | ₹7141.58 - ₹8728.60 | +8.6% | ROE: 17.9%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹2838.59 | ₹2554.73 - ₹3122.45 | -61.1% | EPS: ₹113.24, BVPS: ₹3162.45 |
| Dividend Yield Method | dividend | ₹2191.50 | ₹1972.35 - ₹2410.65 | -70.0% | DPS: ₹30.00, Target Yield: 2.5% |
DIVISLAB Intrinsic Value vs Market Price — All Valuation Models
Divis Laboratories fair value range ₹2192–₹8219 vs current market price ₹7305.00 across 10 valuation models. Read Divis Laboratories dividend policy for the complete payout history and dividend yield track record.
DIVISLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Divis Laboratories median intrinsic value ₹4507.17, current price ₹7305.00 — Trading Above Calculated Value by 38.3%, margin of safety -62.1%.
What is the intrinsic value of DIVISLAB?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Divis Laboratories (DIVISLAB) is ₹4507.17 (median value). With the current market price of ₹7305.00, this represents a -38.3% variance from our estimated fair value.
The valuation range spans from ₹2191.50 to ₹8218.87, indicating ₹2191.50 - ₹8218.87.
Is DIVISLAB undervalued or overvalued?
Based on our multi-method analysis, Divis Laboratories (DIVISLAB) appears to be trading above calculated value by approximately 38.3%.
DIVISLAB Financial Health — Key Ratios vs Industry Benchmarks
Divis Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.03 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 33.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.60x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
DIVISLAB Cash Flow Quality — Operating & Free Cash Flow
Divis Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2,738 Cr | ₹1,629 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,653 Cr | ₹1,251 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹1,261 Cr | ₹1,127 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹2,460 Cr | ₹1,106 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹1,912 Cr | ₹815 Cr | Positive Free Cash Flow | 7/10 |